N🟁N

ROCK, NUVA, ABC, TPX, SGMO, ACTG Are Seasonally Ripe To Go Up In the Next Five Weeks

November 22, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Gibraltar Industries Inc. (NASDAQ:ROCK), NuVasive, Inc. (NASDAQ:NUVA), AmerisourceBergen Corporation (NYSE:ABC), Tempur Sealy International Inc. (NYSE:TPX), Sangamo BioSciences Inc. (NASDAQ:SGMO), Acacia Research Corporation (NASDAQ:ACTG) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  ROCK    Gibraltar Industries Inc.        13.98%           82.61% (19 of 23)    Wednesday, December 28th 2016
  NUVA    NuVasive, Inc.                   5.14%            91.67% (11 of 12)    Thursday, December 22nd 2016
  ABC     AmerisourceBergen Corporation    1.83%            90.48% (19 of 21)    Tuesday, November 29th 2016
  TPX     Tempur Sealy International Inc.  3.03%            91.67% (11 of 12)    Tuesday, November 29th 2016
  SGMO    Sangamo BioSciences Inc.         9.29%            93.75% (15 of 16)    Monday, November 28th 2016
  ACTG    Acacia Research Corporation      11.52%           84.62% (11 of 13)    Monday, December 5th 2016

Gibraltar Industries Inc. (NASDAQ:ROCK) - Gibraltar Industries, Inc. manufactures and distributes building products in North America, Europe, and Asia. Its Residential Products segment offers roof and foundation ventilation products and accessories, including solar powered units; postal and parcel storage products, such as single mailboxes, cluster boxes for multi-unit housing, and package delivery systems; roof edgings and flashings; soffits and trims; drywall corner beads; metal roofing and accessories; rain dispersion products consisting of gutters and accessories; and exterior retractable awnings. This segment also provides electronic parcel lockers, roof top safety kits, chimney caps, heat trace coils and exterior, remote-controlled deck awnings for sun protection, and solar-powered ventilation products. The company s Industrial and Infrastructure Products segment offers fabricated bar grating and safety plank grating used in industrial flooring, walkways, stairs, platforms, safety barriers, drainage covers, and ventilation grates; expanded and perforated metals used in walkways, catwalks, automotive trims, shelving, fencing, barriers, and other applications, where visibility and security are necessary; fiberglass grating; and expansion joint systems, bearing assemblies, and pavement sealing systems used in bridges, elevated highway, airport runways, and rail crossings. This segment also provides architectural facades for buildings, front grilles for truck tractor manufacturers; interior ceilings and lighting fixtures; and outdoor railings and balustrades. Its Renewable Energy and Conservation segment designs and provides engineered solutions for solar racking systems and greenhouse structures. The company markets its products through sales personnel and outside sales representatives. Gibraltar Industries, Inc. was founded in 1993 and is headquartered in Buffalo, New York..

NuVasive, Inc. (NASDAQ:NUVA) - NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. The company s principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring (IMO) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologics products are used for spinal fusion or bone healing process, including Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; Propel DBM, a moldable demineralized bone matrix putty; and Osteocel Plus and Osteocel Pro, an allograft (donated human tissue) cellular matrix. The company s IMO services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis (EOS), a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to surgeons, hospitals, and other customer through independent sales agents, directly-employed sales forces, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California..

AmerisourceBergen Corporation (NYSE:ABC) - AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; and supply management software and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. AmerisourceBergen Corporation markets its products and services through independent sales forces and marketing organizations. The company was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania..

Tempur Sealy International Inc. (NYSE:TPX) - Tempur Sealy International, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes bedding products worldwide. It operates through two segments, North America and International. The company provides mattresses, foundations, and adjustable bases, as well as other products comprising pillows, mattress covers, sheets, cushions, and various comfort products. It offers its products under the TEMPUR, Tempur-Pedic, Sealy, Sealy Posturepedic, Optimum, and Stearns & Foster brand names. The company sells its products through furniture and bedding retailers, department stores, specialty retailers, and warehouse clubs; e-commerce platforms, company-owned stores, and call centers; and other third party distributors, and hospitality and healthcare customers. It is also involved in licensing its Sealy, and Stearns & Foster brands, technology, and trademarks to other manufacturers. Tempur Sealy International, Inc. was founded in 1989 and is headquartered in Lexington, Kentucky..

Sangamo BioSciences Inc. (NASDAQ:SGMO) - Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. Its proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome modification and gene regulation. The ZFPs could also be linked to a cleavage domain of a restriction endonuclease to create zinc finger nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off. Its lead ZFP Therapeutic candidate includes SB-728-T, a ZFN-mediated autologous cell product for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I/II clinical trials. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B and MPS I, a lysosomal storage disorder (LSD); and proprietary preclinical programs in hemophilia A and other LSDs. It has collaborative partnerships with Biogen Inc. (Biogen) to research, develop, and commercialize the preclinical ZFP Therapeutic development program in hemoglobinopathies, including sickle cell disease and beta-thalassemia; and with Shire International GmbH to research, develop, and commercialize the preclinical ZFP Therapeutic development program in Huntington s disease. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California..

Acacia Research Corporation (NASDAQ:ACTG) - Acacia Research Corporation, through its subsidiaries, invests in, develops, licenses, and enforces patented technologies in the United States. It assists patent owners with the prosecution and development of their patent portfolios; the protection of their patented inventions from unauthorized use; the generation of licensing revenue from users of their patented technologies; and enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The company owns or controls the rights to various patent portfolios, which include the United States patents and foreign counterparts covering technologies used in various industries. It has approximately 1,490 license agreements and 185 patent portfolio licensing and enforcement programs. Acacia Research Corporation was founded in 1992 and is headquartered in Newport Beach, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net